| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,298 | 9,740 | 8,491 | 7,991 | | Cost of Revenue | 3,739 | 4,109 | 2,538 | 4,556 | | | Gross Profit | 5,559 | 5,631 | 5,953 | 3,435 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,763 | 3,065 | 2,246 | 4,979 | | Non Recurring |
-
| (867) | (6,179) | 7,695 | | Others |
-
| 154 | 87 | 320 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,796 | 3,279 | 9,799 | (9,559) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 32 | 58 | 73 | | Earnings Before Interest And Taxes | 1,836 | 3,311 | 9,857 | (9,486) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,836 | 3,311 | 9,857 | (9,486) | | Income Tax Expense | 127 | (136) | 109 | 1,210 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,709 | 3,447 | 9,748 | (10,696) | | | Non-recurring Events | | Discontinued Operations | (53) | (3,361) | (14,536) | (228) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,656 | 86 | (4,788) | (10,924) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,656 | $86 | ($4,788) | ($10,924) |
|
0.51% Nasdaq 
0.01 (0.11%) 
Income Statement
